FIELD: organic chemistry, medicine.
SUBSTANCE: invention represents new dithiepino[6,5-b]pyridines of the formula (I)
and (II)
wherein radical values are given in the invention claim. Compounds are useful as antagonists of calcium channels and eliciting cardiovascular, anti-asthmatic and broncholytic activities. Invention relates also to pharmaceutical compositions and methods for prophylaxis and treatment of disorders, such as enhanced sensibility, allergy, asthma, bronchospasm, dysmenorrhea, esophagospasm, glaucoma, premature delivery, disorders in urinary ways, disorders in motoric function of digestive tract and cardiovascular disorders.
EFFECT: improved preparing method, valuable medicinal properties of compounds.
27 cl, 7 tbl, 15 ex
| Title | Year | Author | Number |
|---|---|---|---|
| OXATHIEPINO[6,5-B]DIHYDROPYRIDINES AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 2000 |
|
RU2257388C2 |
| TRICYCLIC DERIVATIVES, PREPARATION METHOD, PHARMACEUTICAL COMPOSITION, AND METHOD OF INHIBITION OF VASOPRESSINE | 1994 |
|
RU2149160C1 |
| BICYCLIC PYRIDINE DERIVATIVES USEFUL AS FATTY ACID BINDING PROTEIN (FABP) 4 AND / OR 5 INHIBITOR | 2013 |
|
RU2648247C2 |
| PYRROLOPYRAZINE KINASE INHIBITORS | 2012 |
|
RU2673064C2 |
| DERIVATIVES OF BENZOXAZEPINE, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND THEIR USING AS AGONISTS OF AMPA RECEPTOR | 2002 |
|
RU2279434C2 |
| DERIVATIVES OF CARBOXYLIC ACIDS (VARIANTS), PHARMACEUTICAL COMPOSITION AND METHOD FO SELECTIVE BINDING αβ-INTEGRIN IN MAMMAL | 2000 |
|
RU2263109C2 |
| HETEROCYCLIC INHIBITORS OF Hh-SYGNAL CASCADE, BASED ON THEM MEDICINAL COMPOSITIONS AND METHOD OF TREATING DISEASES INDUCED BY ABBARANT ACTIVITY OF Hh-SIGNAL SYSTEM | 2007 |
|
RU2364597C1 |
| METHOD OF PREPARING (1,4)-DITHIEPINO (2,3-C)-PYRROLE OR ITS SALTS | 0 |
|
SU869559A3 |
| 2, 5, 6, 7-TETRAHYDRO-[1, 4]OXAZEPIN-3-YLAMINES OR 2, 3, 6, 7-TETRAHYDRO-[1, 4]OXAZEPIN-5-YLAMINES | 2011 |
|
RU2570796C2 |
| PYRAZOLPYRIMIDINE COMPOUNDS JAK INHIBITORS AND METHODS | 2009 |
|
RU2539568C2 |
